| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 113237 | Null | 1.80303315873685e-005 | 0.51037977 |
| NSC 755423 | Null | 1.80303315873685e-005 | 0.61311564 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 2.16417361041569e-005 | 0.26144729 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 2.16417361041569e-005 | 0.51175092 |
| NSC 736994 | 1-(naphthalen-2-yl)-2-(3,4,5-trimethoxyphenyl)-1H-imidazole | 2.16417361041572e-005 | 0.34713024 |
| NSC 756406 | GW852849X | 2.16417361041572e-005 | 0.34331598 |
| NSC 756407 | GW853606X | 2.16417361041572e-005 | 0.30251186 |
| NSC 174121 | Methotrexate Derivative | 3.25006101781773e-005 | 0.57894706 |
| NSC 763587 | Null | 3.2500610178177e-005 | 0.44484082 |
| NSC 755417 | Null | 3.84182410752305e-006 | 0.50713983 |